Inari Medical, Inc. - Common Stock (NARI)
Frequently Asked Questions About Inari Medical, Inc. - Common Stock (NARI)
How can investors find information about Inari Medical's financial performance?
Investors can find information about Inari Medical's financial performance by visiting the company's investor relations website, where they provide quarterly earnings reports, SEC filings, press releases, and other financial data. Additionally, the company engages in earnings calls and presentations to discuss its financial status and strategic direction.
How does Inari Medical engage with healthcare professionals?
Inari Medical engages with healthcare professionals through educational initiatives, training workshops, and conferences. The company recognizes the importance of collaboration with clinicians to understand their needs and gather feedback that can drive product innovation and improve patient care.
How does Inari Medical ensure product safety?
Inari Medical places a high priority on product safety and quality control. The company adheres to rigorous regulatory standards and guidelines set forth by the FDA and other governing bodies. They conduct extensive clinical trials and testing to validate the safety and effectiveness of their products before market release.
How does Inari Medical handle customer feedback?
Inari Medical values customer feedback and uses it to continuously improve its products and services. The company actively seeks input from healthcare professionals and patients through surveys and direct communication, ensuring that their innovations align with clinical needs and preferences.
How does Inari Medical support patient education?
Inari Medical supports patient education by providing resources and information about venous diseases and the available treatment options. They aim to empower patients to make informed decisions about their health by collaborating with healthcare providers and creating educational materials that are easily accessible.
Is Inari Medical involved in clinical trials?
Yes, Inari Medical is actively involved in clinical trials to evaluate the safety and efficacy of its medical devices. These trials are essential for gathering data to support product development, regulatory submissions, and to ultimately inform clinical practices in the treatment of venous diseases.
Is Inari Medical publicly traded?
Yes, Inari Medical is a publicly traded company listed on the Nasdaq stock exchange under the ticker symbol NARI. The company went public in March 2021, providing it with the capital to accelerate its growth and expand its product offerings.
What are Inari Medical's growth plans?
Inari Medical's growth plans involve expanding its product portfolio and increasing market penetration in venous health. The company aims to enhance its existing technologies and explore new therapeutic areas, as well as expand its global footprint through strategic partnerships and collaborations.
What challenges does Inari Medical face?
Like many companies in the medical device sector, Inari Medical faces challenges such as regulatory hurdles, market competition, and the need to constantly innovate to meet evolving healthcare demands. Additionally, reimbursement policies can impact adoption rates of new technologies, posing further challenges for the company.
What does Inari Medical, Inc. do?
Inari Medical, Inc. is a medical device company focused on transforming the treatment of venous diseases. The company develops innovative, minimally invasive therapies to treat conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). By utilizing advanced technologies, Inari aims to improve patient outcomes and streamline procedures for healthcare providers.
What is Inari Medical's approach to sustainability?
Inari Medical is committed to sustainability through responsible corporate practices and eco-friendly operations. The company seeks to minimize its environmental impact by using sustainable materials in product design and manufacturing, as well as promoting waste reduction across its facilities.
What is the ClotTriever System?
The ClotTriever System is Inari Medical's flagship product designed for the treatment of DVT and PE. It is an innovative, thrombectomy device that enables physicians to effectively remove thrombus from the venous system through a minimally invasive procedure, improving patient recovery times and outcomes.
What is the mission of Inari Medical?
Inari Medical's mission is to improve the lives of patients suffering from venous diseases by providing advanced treatment options. The company is dedicated to delivering safe, effective, and minimally invasive technologies that lead to better clinical outcomes and increased patient satisfaction.
What motivates Inari Medical's research and development?
Inari Medical's research and development efforts are motivated by the goal of addressing unmet clinical needs in the treatment of venous diseases. The company invests heavily in innovation and clinical research to develop new products and enhance existing technologies that can significantly improve patient care.
What products does Inari Medical offer?
Inari Medical offers a range of products designed for the treatment of venous diseases, including devices specifically for clot removal in cases of DVT and PE. Their flagship product, the ClotTriever, is a fully integrated system that simplifies the clot retrieval process while enhancing efficiency and safety.
What role does technology play in Inari Medical's products?
Technology is at the core of Inari Medical's products, with a strong emphasis on innovation and design. The company leverages advanced engineering and materials science to develop devices that enhance procedural efficiency, improve clinical outcomes, and provide greater safety for both patients and clinicians.
When was Inari Medical, Inc. founded?
Inari Medical was founded in 2011 by a team of experienced professionals in the medical device industry. The company was established with the vision of addressing complex venous disorders using innovative, effective technologies that enhance patient care.
Where is Inari Medical located?
The headquarters of Inari Medical is located in Irvine, California. This strategic location places the company in a significant medical and technological hub, allowing them to attract top talent and collaborate with leading medical institutions.
Who are Inari Medical's primary competitors?
Inari Medical operates in a competitive landscape, with several notable competitors including Boston Scientific, Medtronic, and Penumbra, Inc. These companies also offer devices and therapies for venous disease treatment and are continuously innovating to improve their product offerings.
Who are the key executives at Inari Medical?
The key executives at Inari Medical include co-founder and CEO Bill Wells, who has extensive experience in the medical device industry, and other members of the leadership team who bring expertise in operations, clinical affairs, and commercialization. Their collective experience drives the company’s strategic vision and growth.
What is the current price of Inari Medical, Inc. - Common Stock?
The current price of Inari Medical, Inc. - Common Stock is 79.97
When was Inari Medical, Inc. - Common Stock last traded?
The last trade of Inari Medical, Inc. - Common Stock was at 4:00 pm EST on February 18th, 2025
What is the market capitalization of Inari Medical, Inc. - Common Stock?
The market capitalization of Inari Medical, Inc. - Common Stock is 4.34B
How many shares of Inari Medical, Inc. - Common Stock are outstanding?
Inari Medical, Inc. - Common Stock has 54.31M shares outstanding.